Broncast 5 mg is a pediatric medication designed for children aged 6 to 14 years, providing additional asthma control when inhaled corticosteroids are insufficient.
Key Features
- Contains Montelukast Sodium for effective asthma management.
- Specifically formulated for children aged 6 to 14 years.
- Provides additional asthma control alongside inhaled corticosteroids.
- Offers short-term relief from asthma symptoms.
- Convenient chewable tablet form for easy administration.
- Helps improve overall asthma management for mild to moderate cases.